Evidence map›Paper›PMID 22802970›Full record

ArticlePloS one2012

The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles.

Christian A Ruge, Ulrich F Schaefer, Jennifer Herrmann, Julian Kirch, Olga Cañadas, Mercedes Echaide, Jesús Pérez-Gil, Cristina Casals, Rolf Müller, Claus-Michael Lehr

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 157 citations in OpenAlex.

  1. Review
  2. Article
  3. Nanoparticle-Based Pulmonary Immune Engineering.Annual review of chemical and biomolecular engineering · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Nanoparticle systems for cancer vaccine.Nanomedicine (London, England) · 2019
    Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Christian A RugeDepartment of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany.
Ulrich F Schaefer
Jennifer Herrmann
Julian Kirch
Olga Cañadas
Mercedes Echaide
Jesús Pérez-Gil
Cristina Casals
Rolf Müller
Claus-Michael Lehr
Saarland University · DEUniversidad Complutense de Madrid · ESHelmholtz Institute for Pharmaceutical Research Saarland · DECentro de Investigación Biomédica en Red · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The peripheral lungs are a potential entrance portal for nanoparticles into the human body due to their large surface area. The fact that nanoparticles can be deposited in the alveolar region of the lungs is of interest for pulmonary drug delivery strategies and is of equal importance for toxicological considerations. Therefore, a detailed understanding of nanoparticle interaction with the structures of this largest and most sensitive part of the lungs is important for both nanomedicine and nanotoxicology. Astonishingly, there is still little known about the bio-nano interactions that occur after nanoparticle deposition in the alveoli. In this study, we compared the effects of surfactant-associated protein A (SP-A) and D (SP-D) on the clearance of magnetite nanoparticles (mNP) with either more hydrophilic (starch) or hydrophobic (phosphatidylcholine) surface modification by an alveolar macrophage (AM) cell line (MH-S) using flow cytometry and confocal microscopy. Both proteins enhanced the AM uptake of mNP compared with pristine nanoparticles; for the hydrophilic ST-mNP, this effect was strongest with SP-D, whereas for the hydrophobic PL-mNP it was most pronounced with SP-A. Using gel electrophoretic and dynamic light scattering methods, we were able to demonstrate that the observed cellular effects were related to protein adsorption and to protein-mediated interference with the colloidal stability. Next, we investigated the influence of various surfactant lipids on nanoparticle uptake by AM because lipids are the major surfactant component. Synthetic surfactant lipid and isolated native surfactant preparations significantly modulated the effects exerted by SP-A and SP-D, respectively, resulting in comparable levels of macrophage interaction for both hydrophilic and hydrophobic nanoparticles. Our findings suggest that because of the interplay of both surfactant lipids and proteins, the AM clearance of nanoparticles is essentially the same, regardless of different intrinsic surface properties.

Indexed as

NanoparticlesAdsorptionAnimalsCell LineHumansHydrophobic and Hydrophilic InteractionsMacrophages, AlveolarMicePhosphatidylcholinesPulmonary AlveoliPulmonary Surfactant-Associated Protein APulmonary Surfactant-Associated Protein DStarchSurface PropertiesPhosphatidylcholinesPulmonary Surfactant-Associated Protein APulmonary Surfactant-Associated Protein DStarch

Identifiers

PMID22802970
PMCPMC3393659
OpenAlexW2083648308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.